Mini Oral Abstract Sessions—Tuesday, September 25, 2018MA15.02 Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2018 Published by Elsevier Inc.